Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Fatty Acids and Conjugates [FA01]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA01020366 29:2(5Z,9Z)(26Me) 26-methyl-5Z,9Z-octacosadienoic acid FA 30:2 C30H56O2 448.428031
LMFA01020366 29:2(5Z,9Z)(26Me) 26-methyl-5Z,9Z-octacosadienoic acid FA 30:2 C30H56O2 448.428031
LMFA01030909 21:1(7Z) 7Z-heneicosenoic acid FA 21:1 C21H40O2 324.302831
LMFA08020234 N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide C29H55N3O3 493.424342
LMFA08020234 N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide N,N-bis(4-acetamidobutyl)-15-methylhexadec-6E-enamide C29H55N3O3 493.424342
LMFA07070061 Docosa-4,7,10,13,16-pentaenoyl carnitine 3-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyloxy]-4-(trimethylazaniumyl)butanoate CAR 22:5 C29H47NO4 473.350510
LMFA04030004 Resolvin D6 4S,17S-dihydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230061
LMFA04030004 Resolvin D6 4S,17S-dihydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230061
LMFA04030005 AT-Resolvin D1 7S,8R,17R-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O3 C22H32O5 376.224976
LMFA04030005 AT-Resolvin D1 7S,8R,17R-trihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:6;O3 C22H32O5 376.224976
LMFA04030009 8-oxo-Resolvin D1 8-oxo-7S,17S-dihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:7;O3 C22H30O5 374.209326
LMFA04030009 8-oxo-Resolvin D1 8-oxo-7S,17S-dihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:7;O3 C22H30O5 374.209326
LMFA04030009 8-oxo-Resolvin D1 8-oxo-7S,17S-dihydroxy-4Z,9E,11E,13Z,15E,19Z-docosahexaenoic acid FA 22:7;O3 C22H30O5 374.209326
LMFA02000422 6(Z),9(Z),12(Z)-18-HOTrE 18-hydroxyoctadeca-6Z,9Z,12Z-trienoic acid FA 18:3;O C18H30O3 294.219496
LMFA02000422 6(Z),9(Z),12(Z)-18-HOTrE 18-hydroxyoctadeca-6Z,9Z,12Z-trienoic acid FA 18:3;O C18H30O3 294.219496
LMFA01160006 (2R)-2-[(1R)-1-hydroxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclopropyl}hexadecyl]hexacosanoic acid (2R)-2-[(1R)-1-hydroxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclopropyl}hexadecyl]hexacosanoic acid FA 84:1;O2 C84H166O4 1239.278613
LMFA01160006 (2R)-2-[(1R)-1-hydroxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclopropyl}hexadecyl]hexacosanoic acid (2R)-2-[(1R)-1-hydroxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclopropyl}hexadecyl]hexacosanoic acid FA 84:1;O2 C84H166O4 1239.278613
LMFA01160006 (2R)-2-[(1R)-1-hydroxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclopropyl}hexadecyl]hexacosanoic acid (2R)-2-[(1R)-1-hydroxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclopropyl}hexadecyl]hexacosanoic acid FA 84:1;O2 C84H166O4 1239.278613
LMFA01160006 (2R)-2-[(1R)-1-hydroxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclopropyl}hexadecyl]hexacosanoic acid (2R)-2-[(1R)-1-hydroxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclopropyl}hexadecyl]hexacosanoic acid FA 84:1;O2 C84H166O4 1239.278613
LMFA03020072 Delta(6)-trans,Delta(8)-cis-leukotriene B4 (5S,6E,8Z,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid FA 20:4;O2 C20H32O4 336.230061
LMFA03020072 Delta(6)-trans,Delta(8)-cis-leukotriene B4 (5S,6E,8Z,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid FA 20:4;O2 C20H32O4 336.230061
LMFA01031049 12Z,15Z,18Z-Tetracosatrienoic acid 12Z,15Z,18Z-Tetracosatrienoic acid FA 24:3 C24H42O2 362.318481
LMFA07030018 Type III cyanolipid 18:3 ester (3-cyano-2-methylprop-2E-en-1-yl) 9Z,12Z,15Z-octadecatrienoate C23H35NO2 357.266779
LMFA07030018 Type III cyanolipid 18:3 ester (3-cyano-2-methylprop-2E-en-1-yl) 9Z,12Z,15Z-octadecatrienoate C23H35NO2 357.266779
LMFA07070046 4,8 dimethylnonanoyl carnitine 3-[(4,8-dimethylnonanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 11:0 C18H35NO4 329.256609
LMFA01050451 (9Z)-(7S,8S)-Dihydroxyoctadecenoic acid (Z,7R,8S)-7,8-dihydroxyoctadec-9-enoic acid FA 18:1;O2 C18H34O4 314.245711
LMFA01050451 (9Z)-(7S,8S)-Dihydroxyoctadecenoic acid (Z,7R,8S)-7,8-dihydroxyoctadec-9-enoic acid FA 18:1;O2 C18H34O4 314.245711
LMFA01050514 Hypusine (2S)-2-amino-6-{[(2S)-4-amino-2-hydroxybutyl]amino}hexanoic acid C10H23N3O3 233.173941
LMFA01050514 Hypusine (2S)-2-amino-6-{[(2S)-4-amino-2-hydroxybutyl]amino}hexanoic acid C10H23N3O3 233.173941
LMFA01030949 (E)-10-Oxo-8-decenoic acid (8E)-10-oxodec-8-enoic acid FA 10:2;O C10H16O3 184.109945
LMFA07030011 Type IV cyanolipid 20:2 ester (1-cyano-2-methylprop-2-en-1-yl) 11Z,14Z-eicosadienoate C25H41NO2 387.313729
LMFA07030011 Type IV cyanolipid 20:2 ester (1-cyano-2-methylprop-2-en-1-yl) 11Z,14Z-eicosadienoate C25H41NO2 387.313729
LMFA01050548 9,10-Dihydroxydocosanoic acid 9,10-Dihydroxydocosanoic acid FA 22:0;O2 C22H44O4 372.323961
LMFA08020163 1-(4-carboxybutanamido)-1'-(dimethylcarbamoyl)ferrocene {(1,2,3,4,5-eta)-1-(4-carboxybutanamido)cyclopentadienyl}[(1,2,3,4,5-eta)-1-(dimethylcarbamoyl)cyclopentadienyl]iron C18H22N2O4Fe 386.092898
LMFA08020175 Ferroxamine N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxo-butanoyl]-hydroxy-amino]pentyl]-N'-(5-aminopentyl)-N'-hydroxy-butanediamide;iron C25H48FeN6O8 616.288303
LMFA07010089 Myristoleyl laurate 9Z-tetradecenyl dodecanoate WE 26:1 C26H50O2 394.381081
LMFA01031033 Bosseopentaenoic acid 5Z,8Z,10E,12E,14Z-eicosapenta-enoic acid FA 20:5 C20H30O2 302.224581
LMFA01050450 (7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid (7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid FA 17:3;O3 C17H28O5 312.193676
LMFA01050450 (7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid (7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid FA 17:3;O3 C17H28O5 312.193676
LMFA01050450 (7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid (7Z)-14-hydroxy-10,13-dioxoheptadec-7-enoic acid FA 17:3;O3 C17H28O5 312.193676
LMFA08010022 S-(2-Methylpropionyl)-dihydrolipoamide-E 8-[(2-methylpropanoyl)sulfanyl]-6-sulfanyloctanamide C12H23NO2S2 277.117020
LMFA08010022 S-(2-Methylpropionyl)-dihydrolipoamide-E 8-[(2-methylpropanoyl)sulfanyl]-6-sulfanyloctanamide C12H23NO2S2 277.117020
LMFA08010022 S-(2-Methylpropionyl)-dihydrolipoamide-E 8-[(2-methylpropanoyl)sulfanyl]-6-sulfanyloctanamide C12H23NO2S2 277.117020
LMFA07070013 (2E)-hexenedioylcarnitine 3-{[(2E)-5-carboxypent-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 6:2;O2 C13H21NO6 287.136889
LMFA07070058 Clupanodonyl carnitine 3-[(4E,8E,12E,15E,19E)-docosa-4,8,12,15,19-pentaenoyloxy]-4-(trimethylazaniumyl)butanoate CAR 22:5 C29H47NO4 473.350510
LMFA07070041 3-hydroxyisovalerylcarnitine 3-[(3-hydroxy-3-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 5:0;O C12H23NO5 261.157624
LMFA07070041 3-hydroxyisovalerylcarnitine 3-[(3-hydroxy-3-methylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate CAR 5:0;O C12H23NO5 261.157624
LMFA07070064 Fumarycarnitine (3S)-3-{[(2E)-3-carboxyprop-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 4:2;O2 C11H17NO6 259.105589
LMFA07070088 O-arachidonoylcarnitine 3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-4-(trimethylazaniumyl)butanoate CAR 20:4 C27H45NO4 447.334859
LMFA07070096 O-oleoylcarnitine 3-[(9Z)-octadec-9-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 18:1 C25H47NO4 425.350510